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George Shubinsky and Michael Schlesinger* expression of p190, a high-molecular-weight oligomeric
form of CD38 (Umar et al., 1996). The short cytoplasmicThe Paul Ehrlich Center
for the Study of Normal and Leukemic WBC domain of CD38 contains no known motifs (Src homol-
ogy domain 2 or 3 [SH2 or SH3], antigen receptor activa-The Hubert H. Humphrey Center
for Experimental Medicine and Cancer Research tion [ARAM], or pleckstrin homology [PH]) that could
mediate interactions with other signaling proteins andThe Hebrew UniversityÐHadassah Medical School
Jerusalem 91120 seems to have no enzymatic activity. The cytoplasmic
portion of both murine and rat CD38 contains one tyro-Israel
sine residue that is not conserved in human CD38. The
intracellular part of CD38 contains two conserved serine
During the past two decades significant progress was residues within consensus sites recognized by cyclic
made in understanding the molecular mechanisms of guanosine monophosphate (cGMP)±dependent protein
intracellular signaling that control the growth and devel- kinases (Figure 1). cGMP-dependent serine/threonine
opment of lymphocytes. Numerous cell surface recep- kinases in sea urchin eggs modulate the activity of ADP-
tors were shown to trigger the phosphorylation of intra- ribosyl cyclase, an enzyme that displays a functional
cellular proteins either via their intrinsic cytoplasmic homology to CD38 protein (Lund et al., 1996). The cyto-
kinase domain or via associated intracellular protein ty- plasmic tail of CD38 might therefore serve as a regula-
rosine kinases (PTKs). Protein phosphorylation plays a tory subunit of the CD38 ectoenzyme rather than as a
key role in the initiation and propagation of various sig- tool for transduction of signals into the cell interior.
naling cascades (Chan et al., 1994; Weiss and Littman, A number of CD38-related proteins, such as RT6,
1994; Kim et al., 1993a). The transmembrane signaling BST-1, and Yac-1, are GPI-anchored (Itoh et al., 1994;
by surface receptors with ectoenzymatic activity and the Okazaki and Moss, 1996). In contrast, CD38 is a trans-
mechanisms of their signaling function remain, however, membrane protein, and no GPI-anchored CD38 mole-
poorly understood. Regulatory signals may be gener- cules have been found on the cell surface. The trans-
ated by membrane-associated peptidases CD10/NEP, membrane domain of human CD38 includes 18 residues
CD13/APN, CD26/DPPIV, and yBP-1. Glycosylphospha- of hydrophobic amino acids that are located between
tidylinositol (GPI)±anchored ecto-59 nucleotidase (CD73), two short spacers that contain hydrophylic amino acids.
which mediates lymphocyte-vascular adhesiveness, may Each of these spacers includes a triad of small amino
also participate in the transduction of signals into the acids. It is noteworthy that analogous amino acid se-
cell interior (Shipp and Look, 1993). quences determine GPI-cleavage/anchor sites and are
A novel family of multifunctional membrane ectoen- found in the C terminus of primary translation products
zymes has recently attracted attention. These ectoen- of all known GPI-anchored proteins (Englund, 1993). It
zymes convert nicotinamide adenine dinucleotide (NAD) remains to be seen, therefore, whether this site is impor-
into cyclic adenosine diphosphate ribose (cADP ribose), tant for any functional property of CD38 protein.
hydrolyze cADP ribose to ADP ribose, and in addition Analysis of the extracellular part of CD38 indicates
display NAD:(amino acid) protein±ADP-ribosyl trans- that it may function in attachment to the extracellular
ferase activity. The CD38 surface protein is a member matrix. Thus, human CD38 proteins contain three puta-
of this family and seems to play an important but not tive hyaluronate-binding motifs (HA motifs). Two of these
yet fully understood role in the regulation of lymphocyte HA motifs are localized in the extracellular domain of
function. CD38 proteins were detected in humans, mice, CD38 (amino acid positions 121±129 and 268±276), and
and rats (Reinherz et al., 1980; Howard et al., 1993; one in the cytoplasmic part of the molecule. Murine
Koguma et al., 1994). This family also includes the hu- CD38 contains two HA motifs (Nishina et al., 1994). In
man, murine, and rat bone marrow stromal cell surface addition, four asparagine residues in the extracellular
molecule BP3/BST-1 (Hirata et al., 1994; Itoh et al., 1994; part of CD38 serve as potential carbohydrate-binding
Furuya et al., 1995); the rat T cell differentiation marker sites.
RT6 and its murine and human homologs; Yac-1 and The human CD38 molecule contains 12 conserved
Yac-2 ADP-ribosyl transferases (Okazaki and Moss, cysteines, 11 of which are located in the extracellular
1996); ADP-ribosyl cyclase from sea molluscs (Tohgo domain. Purified human CD38 undergoes stable homo-
et al., 1994); and other ADP-ribosyl transferases. oligomerization induced by thiol-reactive agents (Guida
et al., 1995). It is tempting to speculate that thiol-depen-
Functional Structure of CD38 dent interactions underlie the association of the extra-
Human CD38 protein is a 45 kDa transmembrane glyco- cellular portion of CD38 with other receptors that may
protein with a short N-terminal cytoplasmic part (21 be vital for thesignaling function of CD38. Fourcysteines
amino acids) and a long extracellular domain (Jackson (Cys-119, Cys-160, Cys-173, and Cys-201) play an es-
and Bell, 1990). The gene encoding human CD38 protein sential role in the cADP ribose synthetic and cADP ri-
is located on chromosome 4p15 (Nakagawara et al., bose hydrolytic activity of CD38 (Tohgo et al., 1994). The
1995). Posttranslational modification may lead to the C-terminal part of CD38, including amino acid sequence
273±285 and particularly Cys-275, also contributes to
the NAD glycohydrolytic activity of CD38 (Hoshino et*To whom correspondence should be addressed.
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Figure 1. Functional Structure of the Human CD38 Molecule
al., 1997). Reducing agents such as dithiothreitol, 2-mer- on neurons of human brain (Mizuguchi et al., 1995), pan-
creatic cells (Kato et al., 1995), epithelial cells of thecaptoethanol, or reduced glutathione inhibit the enzy-
matic activity of CD38, suggesting that the disulfide prostate (Kramer et al., 1995), and other cells (cf. Mehta
et al., 1996). In the hematopoietic system, CD38 proteinsbonds are important for the catalytic activity of the CD38
proteins (Tohgo et al., 1994; Zocchi et al., 1995). Com- can be detected on monocytes, myeloid cells, T and B
lymphocytes, natural killer (NK) cells, follicular dendriticputed analysis of the structure of murine Rt6 and its
cells, and even platelets (Alessio et al., 1990; Banche-related proteins from rabbit, humans, and chickens
reau and Rousset, 1992; Ramaschi et al., 1996). Dra-showed that the amino acid sequence within the cata-
matic changes in the expression of CD38 correlate withlytic domain and patterns of secondary structure motifs
the most critical events in the development of humanpredicted for different CD38-related NAD hydrolases
hematopoietic cells. The early stage of maturation ofwere similar to those predicted for bacterial mono±ADP-
primitive CD341 human hematopoietic progenitors intoribosyl transferases (Koch-Nolte et al., 1996). In par-
committed bipotent erythroid/megakaryocytic (burst-ticular, the conserved pair of amino acids Glu-146±Asp-
forming unit±erythroid/megakaryocytic), unipotent my-147 seems to endow ADP-ribosyl transferase activity to
eloid (colony-forming unit/granulocyte±macrophage), andthe CD38 protein (Grimaldi et al., 1995; Okazaki and
lymphoid precursors is associated with the expressionMoss, 1996).
of CD38 (Terstappen et al., 1991; Debili et al., 1996;A number of leucines within the transmembrane and
Oertel et al., 1996). Early T cell precursors that migrateextracellular domains potentially form leucine zipper
to the subcortical area of the thymus are CD381,motifs that can provide association of CD38 with other
and likewise the majority of CD41CD81 double-positiveproteins. Two dileucine (LL) motifs are located in the
cortical thymocytes express this antigen. Further matu-middle of human CD38 proteins. One of these motifs
ration into either CD41 or CD81 single-positive medul-(Leu-149±Leu-150) is conserved for human, murine, and
lary thymocytes and peripheral T lymphocytes isaccom-rat CD38. Intracellular targeting and internalization of
panied by a significant decrease in CD38 expressiondifferent transmembrane proteins requires the LL motif
(Reinherz et al., 1980). Mature human T lymphocytes,within the C terminus of their cytoplasmic domains
with low or undetectable levels of CD38, can be induced(Aiken et al., 1994). The LL motif that is located within
to express CD38 molecules by antigenic and mitogenicthe extracellular part of 45 kDa monomeric CD38 is, of
stimuli (Hercend et al., 1981). Thus, the modulation ofcourse, not accessible to intracellular targeting. How-
CD38 on the T cell lineage strikingly coincides with theever, high-molecular-weight oligomers of CD38 might
two most important events during T cell ontogenesis.contain monomeric subunit(s) within the cell interior, ren-
T cells lose their surface CD38 molecules during thedering the LL motif accessible for intracellular targeting.
acquisition of antigenic specificity and intrathymic
negative selection (von Boehmer, 1992), while mature T
Pattern of the Expression and Immunoregulatory cells gain expression of CD38 in response to various
Activity of CD38 stimuli. The expression of CD38 declines in parallel with
Although CD38 was initially discovered as a differentia- the differentiation of activated CD45RA1 T cells into
tion marker of T lymphocytes (T10), it is now clear that CD45RO1 memory lymphocytes (Prince et al., 1992).
various levels of CD38 can be discovered in a large The distribution of murine CD38 among T cell subsets
differs from the distribution of its human homolog (Lundnumber of cells and tissues. Thus, CD38 has been found
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et al., 1995b). In particular, only a minor subset of murine of CD38 antigen (Oliver et al., 1997), develop potent
proliferative response to anti-CD38 antibodies and IL-4thymocytes displays CD38, and the expression of CD38
(Lund et al., 1995b). Murine spleen B lymphocytesseems to be the hallmark of the independent lineage of
undergo differentiation into IgM-producing cells uponT cell receptor (TCR) ab1CD42CD82 thymocytes, which
stimulation by anti-CD38 and IL-5 (Kikuchi et al., 1995).possess unique regulatory functions (Bean et al., 1995).
Ligation of CD38 on mature murine spleen B cells alsoSimilarly, modulation of CD38 in the human B cell
prevents their apoptotic death elicited by either irradia-lineage synchronizes with critical stages of B cell devel-
tion or dexamethasone (Yamashita et al., 1995).opment. CD38 is expressed on B cell progenitors (pro-B
These and other studies indicate that CD38 is an im-and pre-B cells) that display no surface immunoglobu-
portant regulatory molecule on human, murine, and ratlins (sIg) (Banchereauand Rousset, 1992). The ligation of
lymphocytes. In addition to regulation of apoptoticCD38 on the surface of immature B cells by monoclonal
death in the B cell lineage, CD38 molecules transduceantibodies (MAbs) inhibits their proliferation and elicits
mitogenic signals. Anti-CD38 MAbs elicit proliferationapoptosis (Kumagai et al., 1995; Kitanaka et al., 1996).
of human thymocytes, mature T cells, and NK cellsCytokine-induced down-modulation of CD38 on the
(Malavasi et al., 1994). In cultures of human peripheralcells of an immature B cell lymphoma line was accompa-
blood mononuclear cells, anti-CD38 MAbs induced thenied by increased resistance to agents that elicited cell
synthesis of mRNA of multiple cytokines (Ausiello etdeath (Shubinsky and Schlesinger, 1994). The matura-
al., 1995). Exposure to anti-CD38 MAbs increased thetion of B cell progenitors into sIg-positive antigen-reac-
expression of the a-chain of the IL-5 receptor in murinetive B lymphocytes is accompanied by loss of CD38.
spleen cells (Kikuchi et al., 1995), while murine leukemicMature sIgD1M1 naive B cells are characterized by a
B cells transfected with recombinant CD38 respondedlack of or very low level of CD38. Such cells arepredomi-
to anti-CD38 MAbs by production of IL-2 (Lund et al.,nant in the circulating B lymphocyte pool and in the
1996).mantle zone of lymphoid follicles (Banchereau and
Recently, a 120 kDa protein, Moon-1, was identifiedRousset, 1992; Lagresle et al., 1993; Pascual et al.,
as a natural ligand for human CD38 (Deaglio et al., 1996).1994). The activation of mature virgin B cells induces
The strong expression of Moon-1 on vascular endothe-reexpression of CD38 (Stashenko et al., 1981; Galibert
lial cells provides them with selectin-type adhesiveness
et al., 1996). In lymphoid follicles the expression of CD38
to CD381 hematopoietic cells (Dianzani and Malavasi,
distinguishes the subset of B lymphocytes that are local-
1995). Various levels of expression of Moon-1 were
ized within germinal centers (GCs). CD381 B cells in
found on monocytes, platelets, NK cells, and even T
GCs include a small number of progenitors of GCs and
and B lymphocytes. Thus, CD38 may be involved in the
a large number of activated cells. In the dark zone of
homotypic and heterotypic adhesiveness of lympho-
the GC, CD381 centroblasts undergo intensive mitosis cytes and in the cooperative interactions between T
and activation of the somatic mutation machinery. Divid- cells, B cells, and macrophages. Ligation of CD38 en-
ing centroblasts give rise to CD381 centrocytes, which hances antigen-presenting function in monocytes (Lund
accumulate within the light zone of the GC. Isotype- et al., 1995b) possibly by increase of the expression
switching recombination and substitution of the synthe- of major histocompatibility complex class II molecules
sis of IgM by IgG, IgA or IgE seems to take place in (Santos-Argumedo et al., 1993).
CD381 centrocytes (MacLennan, 1994; Pascual et al., A number of other CD38-related proteins are found
1994; Liu et al., 1996). Selection of B cells in GCs is on the surface of hematopoietic cells. RT6.1 and RT6.2
accompanied by apoptotic death of the majority of are two allelic proteins expressed on mature rat T lym-
CD381 B lymphocytes. Study of the microenvironmental phocytes and on intraepithelial lymphocytes. RT61 T
factors that regulate the selection of CD381 B cells cells prevent the development of autoimmune diabetes
showed that ligation of B cell receptors (BCRs) and in the BB rat (Waite et al., 1996). Rt6, a murine homolog
CD40 proteins prevents apoptosis of CD381 B cells and of rat RT6, is also a T cell±restricted membrane protein.
enhances their proliferation (MacLennan, 1994; Galibert Defective expression of Rt6 seems to constitute part
et al., 1996). Various combinations of soluble CD23, in- of the genetic disposition of the NZW mouse to the
terleukin 1a (IL-1a), IL-2, IL-4, IL-5, and IL-10 caused autoimmune lupus-like disease in (NZB 3 NZW)F1 ani-
terminal differentiation of activated B cells into plasma mals (Koch-Nolte et al., 1995). Human BST-1 and murine
blasts (Banchereau and Rousset, 1992). This process is BP3/BST-1 proteins are widely expressed in different
apparently accompanied by the continuous expression tissues and, particularly on bone marrow stromal cells,
of CD38 (MacLennan, 1994). In contrast, the develop- reticular cells of lymphoid organs and endothelial cells
ment of activated B lymphocytes into memory cells is (Itoh et al., 1994). In murine T-lineage cells, BST-1 serves
characterized by loss of CD38 (Lagresle et al., 1993; as an early marker of immature TCRab1 T cells, and
Pascual et al., 1994). Direct interactions of CD381 B MAbs against BST-1 enhanced the proliferative response
cells with activated T lymphocytes seems to provide the of these cells by CD3 MAbs (Vicari et al., 1996). Two
signals required to generate memory B cells (Lagresle additional NAD-dependent ADP-ribosyl transferases,
et al., 1995). The exposure of mature human B cells Yac-1 and Yac-2, were recentlycloned in murine lymphoid
isolated from GCs to anti-CD38 MAbs also prevented cells (Okazaki and Moss, 1996).
their death, although it had no effect on division of the
cells (Zupo et al., 1994b). This finding indicates that Intracellular Signaling Triggered via CD38
CD38 proteins may be involved in the regulation of B Little is known about the biochemical reactions that
cell differentiation within GC. This is also true for murine mediate CD38-triggered signaling. Ligation of CD38 in-
creases the concentration of intracellular Ca21 in murineGC B cells, which, while expressing only a low level
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lymphocytes (Santos-Argumedo et al., 1993; Kirkham et and with FcgRIII (CD16) on NK cells (Funaro et al., 1993).
The signaling pattern induced in human B cells via CD38al., 1994). Conflicting results were obtained in studies
of the effect of ligation of CD38 on tyrosine phosphoryla- is similar to signaling reactions in various lymphocyte
populations activated via the BCR complex, the CD19/tion of proteins in murine B cells. Following the ligation
of CD38, no detectable tyrosine phosphorylation of pro- CD21 complex, Fcg receptors, or theTCR/CD3 complex.
One common denominator in the activation of T and Bteins was observed in cells of a mature B cell lymphoma
line that was transfected with the CD38 expression vec- cells is the role of p72syk PTK. In activated cells, phos-
phorylated p72syk is associated with PI3K and PLCg andtor (Lund et al., 1996). In contrast, the ligation of CD38
on splenic murine Bcells significantly increased tyrosine seems to enhance their catalytic activity (Weiss and
Littman, 1994; Satterthwaite and Witte, 1996). c-Cbl pro-phosphorylation of proteins with molecular weights of
170, 130, 90, and 80 kDa (Kirkham et al., 1994). One of tooncogene and other phosphoproteinswere also found
in complexes with p72syk (Panchamoorthy et al., 1996).these phosphoproteins was identified as p77 Bruton's
tyrosine kinase (Btk) (Kikuchi et al., 1995). Exciting re- In contrast to CD38-mediated signaling, biochemical
cascades induced via other membrane receptors in-sults were obtained in CD45-null transgenic mice. The
knockout of CD45 protein tyrosine phosphatase (CD45- volve phosphorylation and activation of PTKs from the
Src family, which seem to act upstream to p72syk (WeissPTP) significantly reduced but did not abrogate the pro-
liferation of B cells following CD38 cross-linking (Byth and Littman, 1994; Satterthwaite and Witte, 1996).
Activation of murine splenocytes via CD38 results inet al., 1996). These data indicate that CD38-triggered
signaling can involve CD45-PTP and/or target PTKs reg- the phosphorylation of p77btk, which is a characteristic
trait of the signaling cascade triggered via BCRs. Matureulated by CD45-PTP (Chan et al., 1994).
Pathways involved in CD38 signaling were studied in B lymphocytes from X-linked immunodeficient (xid) mice
are unresponsive to CD38 stimulation. Since the xiddifferent human cell lines. Ligation of CD38 on Jurkat
and MOLT-4 human T leukemic cell lines failed to elicit gene encodes Btk, this finding supports the conclusion
that p77btk is involved inCD38-mediated signal transduc-tyrosine phosphorylation of intracellular proteins (Kon-
tani et al., 1996a). In contrast, in cells of human immature tion (Santos-Argumedo et al., 1995; Yamashita et al,
1995). Using B cell lines transfected with CD38, co-B cell lines anti-CD38 induced rapid and transient ty-
rosine phosphorylation of numerous proteins. These in- cross-linking of CD38 and the BCR lowered the thresh-
old for signaling through the BCR. The coexpression ofclude the tyrosine kinase p72syk, the p120c-cbl protoonco-
gene, the p85 subunit of phosphatidyl inositol 3-kinase the BCR, and particularly of the cytoplasmic tails of
Iga and Igb domains, was required for CD38-mediated(PI3K), phospholipase Cg (PLCg), and nonidentified pro-
teins with molecular masses of 145 and 65 kDa. CD38- signal transduction. In these cells the anti-CD38±induced
response was characterized by influx of extracellularmediated phosphorylation of p72syk was accompanied
by activation of this enzyme. Ligation of CD38 on imma- calcium but was not accomplished by tyrosine phos-
phorylation of cellular proteins. Thus, while the BCRture human B cells did not elicit phosphorylation of p59fyn
and p53/p56lyn PTKs, Vav, and p25rasGAP, and in contrast complex must be present in B cells to render them re-
sponsive toanti-CD38 induced signaling, the expressionto results in mice, had no effect on the phosphorylation
of p77btk (Silvennoinen et al., 1996). A similar pattern of of the BCR and CD38 may not suffice for CD38-induced
tyrosine phosphorylation, seen in murine splenic B cellsphosphorylated proteins was found in cells of the HL-
60 myeloid and THP-1 monocytic cell lines after expo- (Lund et al.,1995a, 1996). CD38 may use thecytoplasmic
tail of the BCR for intracellular signaling, but additionalsure to anti-CD38 (Kontani et al., 1996b). The possibility
that p72syk PTK plays a role in CD38-mediated activation receptors and pathways, not related to the BCR, seem
to be required for the full signaling activity of CD38. Inis supported by the finding that during lymphocyte de-
velopment, p72syk is expressed preferentially incells that human B cells, CD38-induced phosphorylation of pro-
teins did not require at all the expression of either thepresumably display high levels of CD38 (Chan et al.,
1994; Satterthwaite and Witte, 1996). CD38-mediated BCR or any of its components (Silvennoinen et al., 1996).
Moreover, coexpression of CD38 and the TCR/CD3phosphorylation of c-Cbl was accompanied by its asso-
ciation with p85 PI3K and by a significant increase of complex by human T cell lines was not sufficient to
enable signal transduction via the CD38 molecule (Kon-the catalytic activity of PI3K. The activation of PI3K, in
turn, seems to play a critical role in the inhibition of cell tani et al., 1996a). These findings indicate that CD38-
growth by ligation of CD38, since specific inhibitors of triggered signaling cannot be mediated solely via anti-
PI3K effectively rescued normal and leukemic immature gen receptors that transmit signals through associated
B cells from CD38-induced suppression (Kitanaka et Src kinases or other signaling molecules. It can therefore
al., 1996). be suggested that CD38-mediated signals are propa-
These findings indicate that the CD38-triggered sig- gated in different cells, either via distinct pathways or
naling in human B cells involves activation of cellular via pathways shared with other receptors.
PTK. A critical question that remains unresolved, how-
ever, is how the CD38 molecule accomplishes this task
Enzymatic Activity of CD38 and Related Proteinseven though it has no intrinsic capacity to generate
CD38 is one of the first cell surface signaling moleculesphosphorylation events. It can be envisaged that addi-
shown to possess ectoenzymatic activity. It catalyzestional membrane molecules are involved in the transduc-
the hydrolysis of NAD to ADP ribose and also generatestion of CD38-mediated signals. Indeed, surface CD38
cADP ribose (Howardet al., 1993; Takasawa et al., 1993).comodulates with the TCR complex on the surface of
T cells, with the CD19/CD21 complex and sIg on B cells, One intracellular event elicited by the ligation of CD38
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can be satisfactorily explained by its ectoenzymatic ac- 40 kDa proteins were not biochemically characterized
in this study, it is tempting to speculate that the enzymetivity. In murine B cells, anti-CD38 MAb induced a rela-
tively weak but prolonged influx of extracellular Ca21, is similar either to GPI-anchored RT6 or to BST-1 pro-
teins, while the target 40 kDa protein is either identicalwhich preceded the onset of cell division (Kirkham et
al., 1994). cADP ribose generated by the enzymatic or similar to the a-subunit of GTP-binding (G) proteins.
activity of CD38 is a strong inositol 3-phosphate±inde-
pendent Ca21 mobilizing agent, suggesting that modula-
Regulation of CD38tion of the enzymatic activity of CD38 by its ligation
The enzymatic activity of CD38 is affected by variousincreases the influx of Ca21 (Aarhus et al., 1995). Overex-
chemical agents. Zinc ions stimulated the ADP-ribosylpression of human CD38 seems to cause the accumula-
cyclase activityof recombinant CD38, while dramaticallytion of intracellular cADP ribose (Kato et al., 1995; Taka-
inhibiting the NAD glycohydrolase activity of CD38hashi et al., 1995). The accumulation of intracellular
(Kukimoto et al., 1996). Gangliosides inhibited glycohy-cADP ribose may in turn lead to the activation of ryano-
drolase and ADP-ribosyl cyclase activities of CD38dine receptors and subsequently to the mobilization of
(Yokoyama et al., 1996). Extensive dimerization of hu-Ca21 from the intracellular store (Lee et al., 1994). CD38-
man CD38 by reactive thiols diminished both the cyclasemediated Ca21 release from intracellular cADP ribose±
and cADPR hydrolase activity of CD38 (Zocchi et al.,sensitive stores seems to play an important role in the
1995). The prolonged exposure of Farage, a human Bactivation of lymphocytes (Santos-Argumedo et al.,
cell lymphoma line, to IL-4 reduced the amount of CD381993, 1995) and in the regulation of insulin secretion by
antigen expressed on the surface of cells and in cellglucose in CD381 pancreatic b cells (Kato et al., 1995).
lysates. No evidence was obtained for acceleratedThe mechanisms underlying the accumulation of intra-
breakdown or shedding of CD38 molecules followingcellular cADP ribose remain unclear. Cytoplasmic ex-
IL-4 treatment, nor for the accumulation of CD38 mole-pression or internalization of membrane CD38 might
cules in the cell interior. Using various inhibitors andincrease the synthesis of cADP ribose in the cell interior.
activators of protein kinases, the mediatory role of ser-It is possible that extracellular cADP ribose may be
ine/threonine kinases in IL-4±induced down-regulationtransported into the cytoplasm via the cell membrane
of CD38 was demonstrated in these experiments (Shu-and that CD38 may play a role in the cellular uptake of
binsky and Schlesinger, 1997). The exposure of CD382cADP ribose, a role similar to that of ecto-NAD glycohy-
human tonsillar B lymphocytes to phorbol ester, whichdrolase in the uptake of extracellular noncyclic ADP
may affect serine/threonine kinases, resulted in the ac-ribose (Kim et al., 1993b).
celerated expression of CD38 (Zupo et al., 1994a).In addition to generating ADP ribose and cADP ribose,
A number of other observations indicate that serine/CD38 may function as a mono±ADP-ribosyl transferase.
threonine protein kinases are recruited in IL-4±triggeredMono±ADP-ribosyl transferases catalyze posttransla-
signaling. Cytokine binding to monocyte IL-4 receptorstional modification of proteins in which the ADP ribose
induced significant generation of diacylglycerol, an acti-moiety of NAD is transferred to cysteine, arginine, or
vator of protein kinase C (PKC), and was associatedhistidine residues of target proteins. CD38 and CD38-
with translocation of PKCa to a nuclear fraction (Ho etrelated proteins share within their catalytic sites amino
al., 1994). IL-4 increased the activity of PI3K in a humanacid sequences similar to those found in eukariotic
Burkitt lymphoma cell line and elicited the translocationmono±ADP-ribosyl transferases and in bacterial toxin
of PKCz from the cytosol to the membrane fraction (Iki-transferases (Okazaki and Moss, 1996). Recombinant
zawa et al., 1996). Serine/threonine kinase Raf-1 wasmurine CD38 was shown to elicit autoribosylation and to
required for IL-4±induced proliferation of myeloid and Tribosylate a number of different proteins at theircysteine
cell lines (Muszynski et al., 1995). The IL-4 signalingresidues (Grimaldi et al., 1995). ADP-arginine ribosyl
cascade involves activation, by tyrosine phosphoryla-transferase activity was detected in the rat T cell differ-
tion, of janus family kinases, and of two additional sub-entiation antigen RT6 and in its murine homolog Rt6.
strates, a signal transducing factor (STF-IL-4) and 4PS/Ligation of RT6 by specific antibody induced its autori-
IRS2. Jak kinases can phosphorylate 4PS/IRS2, sug-bosylation. Murine Rt6 protein can catalyze ADP ribo-
gesting a pathway by which cytokine receptors inducesylation of the light chains of immunoglobulins (Koch-
the phosphorylation of 4PS (Johnston et al., 1995; PernisNolte et al., 1996). A number of observations indicate
et al., 1995). The mechanisms linking these events withthat ADP ribosylation may affect signal transduction.
activation of serine/threoninekinases followed by dimin-ADP ribosylation of low-molecular-weight Rho p21 mes-
ished expression of CD38 has yet to be defined.senger protein decreased the tyrosine phosphorylation
Transretinoic acid (TRA) increases the expression ofof p43 mitogen-activated protein kinase, of p125 focal
CD38 in hematopoietic cells (Drach et al., 1994). TRAadhesion kinase, and of other proteins, and inhibited
also stimulates the synthesis of cADP ribose in renalthe phosphorylation and catalytic activity of PI3K (Ku-
epithelial cells (Beers et al., 1995), suggesting the possi-magai et al., 1993). In cytotoxic T lymphocytes, a GPI-
bility that retinoids may induce the expression of CD38anchored membrane ectoenzyme ribosylated 40 kDa
or related proteins in different cells. The augmentaryproteins associated with p56lck tyrosine kinase. ADP ri-
effect of TRA on the expression of CD38 is mediatedbosylation of p40 adapter proteins inhibited the kinase
by nuclear retinoic acid receptor a (RARa), which actsactivity of p56lck and, concomitantly, diminished prolifer-
as a ligand-inducible transcription factor (Drach et al.,ation and cytotoxic activity of T cells activated by cross-
1994). Activation of PKC by phorbol ester inhibited thelinking of either TCR or CD8 receptors (Wang et al.,
1996). Although the ADP-ribosyl transferase and target expresson of RARa (Kumar et al., 1994). Moreover,
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Figure 2. Hypothetical Model for the Signal-
ing Activity of CD38
PKCa may reduce the DNA-binding capacity of RARa various stages of cell development. For instance, coor-
dinated expression of CD38 and PC-1, a nucleotideby the phosphorylation of RARa molecules and diminu-
tion of their ability to form homodimeric and heterodi- phosphodiesterase, might allow activated lymphocytes
to reutilize NAD and nucleotides from dead cells (Deterremeric complexes (Tahayato et al., 1993). These data
indicate that down-modulation of CD38 by activated et al., 1996). The expression of CD38 can also provide
activated cells with ADP ribose, which is utilized byserine/threonine kinases may result from reduced pro-
poly±ADP-ribosyl transferases to repair extensive DNAduction and impaired binding of RAR transcription factor
damage induced by apoptogenic agents.to DNA.
The signaling function of CD38 may result from en-Recently, it was shown that cytoplasmic transgluta-
hanced Ca21 influx in activated cells, which in turn isminase may convert low-molecular-weight CD38 into a
elicited by cADP ribose. An intriguing hypothesis is thatp190 high-molecular-weight form (Umar et al., 1996).
the immunoregulatory properties of CD38 molecules areThe expression of transglutaminase was augmented by
based on their ability to ribosylate other signaling pro-TRA (Zhang et al., 1995), while the activation of serine/
teins (Figure 2). Various intracellular enzymes may servethreonine kinase, and particularly of PKC, seemed to
as targets for the regulatory modification by ADP-ribosyldown-regulate the transcription of the transglutaminase
transferases (Okazaki and Moss, 1996). Hematopoieticgene (Liew and Yamanishi, 1992). The involvement of
and lymphoid cells may accordingly employ mecha-activated serine/threonine kinases in the down-regula-
nisms whereby membrane ADP-ribosyl transferases,tion of both CD38 and transglutaminase suggests that
and particularly CD38, are internalized and modify intra-the IL-4±induced modulation of CD38 may result in part
cellular substrates. No evidence, however, was obtainedfrom lower level of the expression of transglutaminase.
so far for the internalization of CD38. Alternatively, CD38
and related proteins may exert their effect on other
How CD38 Can Contribute to the Regulation membrane proteins. Recent experiments with TRA-
of Lymphocyte Development treated HL-60 cells give rise to the hypothesis that G
CD38 is a lymphocyte differentiation marker the expres- proteins from the Gs family may be involved in CD38
sion of which coincides with critical stages in lympho- signaling. Cholera toxin is known to ADP ribosylate the
cyte development and with activation of T and B cells. a-subunit of Gs proteins. The exposure of HL-60 human
The expression of CD38 is regulated by cytokines and myeloid cells to TRA decreased the ADP ribosylation of
by other regulatory molecules. The immunoregulatory Gs proteins catalyzed by cholera toxin (de Cremoux et
activity of CD38 seems to result from its signaling func- al., 1991). Treatment of HL-60 cells with TRA dramati-
tion. Various surface proteins were shown to employ for cally increased the expression of CD38 protein (Drach
their signaling function two interlinked properties. They et al., 1994). The decreased availability of a-subunits
recognize and bind specific ligands and mediate the to ADP ribosylation by bacterial toxins might therefore
phosphorylation of intracellular proteins either by intrin- result from TRA-induced expression of CD38, which in
sic catalytic domains or by associated intracellular en- itself exerted ribosylation of proteins, preventing them
zymes. The CD38 molecules and CD38-related proteins from further ribosylation by bacterial toxin. ADP ribo-
are unique since they possess not only receptor and sylation of Gs proteins in turn can cause intracellular
signaling functions but also are endowed with ectoenzy- signaling via the activation of adenylate cyclase (Kahn
matic activity. The relation between these three proper- and Gilman, 1984).
ties of CD38 remains to be clarified. One possibility is Recent findings indicate that G proteins are associ-
that the enzymatic activity of CD38 is not a prerequisite ated with various PTKs via PH domains and glycolipid-
enriched membrane domains. Particularly, p72syk PTK isfor its signaling function and contributes differently in
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